Delivery Order SPE2DR25D1053-SPE2DR26FT471
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 24, 2025, for the supply of Lamictal XR 300 mg tablets (30-count units) valued at $15,910.51 under a firm fixed-price contract. This non-set-aside award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026. The place of performance is AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on November 26, 2025, for the supply of Lamictal XR 50 mg tablets (30-count unit) valued at $1,629.60. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The order is scheduled for completion by November 28, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania facility. AmerisourceBergen Drug Corp, a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of Lamictal XR 200 mg tablets (30-count units) with a ceiling value of $17,458.24. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded through an open process. The place of performance is the vendor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of October 29, 2025. This delivery order is a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Lamictal XR 200 mg tablets (30-count units) with a ceiling value of $1,860.42. This firm fixed-price delivery order, with an ultimate completion date of December 2, 2025, represents a competitively awarded contract with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a Firm Fixed Price delivery order valued at $10,187.98 to AmerisourceBergen Drug Corp for Lamictal XR 200 mg tablets (30-count units) on August 18, 2025, with an ultimate completion date of August 19, 2025. This non-competitive award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The performance location is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Lamictal XR 300 mg tablets (30-count) valued at $9,889.10, with an ultimate completion date of August 7, 2025. This firm fixed-price, competitively awarded contract (no set-aside used) was executed on August 6, 2025, with performance at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a purchase of pharmaceutical inventory supporting federal medical supply...
- The Defense Logistics Agency awarded a delivery order valued at $2,110.58 to AmerisourceBergen Drug Corp for the supply of Lamictal XR 50 mg tablets (30-count) on August 19, 2025, with completion scheduled for August 20, 2025. This is a firm fixed price delivery order issued without a set-aside designation, indicating competitive award under open competition. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at...
- The Defense Logistics Agency awarded a $8,951.56 delivery order to AmerisourceBergen Drug Corp for 30-count bottles of Lamictal XR 300 mg tablets, with an ultimate completion date of September 16, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Lamictal XR 200 mg tablets (30-count units) under a firm fixed-price contract valued at $5,644.62, with an ultimate completion date of April 28, 2025. This non-competitive, non-set-aside delivery order represents a standard pharmaceutical procurement transaction sourced from AmerisourceBergen's extensive federal contract portfolio. The place of performance is the vendor's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $42,766.34 to AmerisourceBergen Drug Corp for the supply of Lamictal XR 200 mg tablets (30-count units) on August 18, 2025, with an ultimate completion date of August 19, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- SPE2DR25D1053Indefinite Delivery Contract
- SPE2DR25D1053-SPE2DR26FT471Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of Lamictal XR 200 mg tablets (30-count units) under a firm fixed-price contract valued at $9,871.83, with an ultimate completion date of October 31, 2025. This non-set-aside competitive award represents a routine pharmaceutical procurement supporting federal medical supply requirements. The awardee, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products, vaccines, and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. The current delivery order for Lamictal XR represents a small-value transaction typical of the numerous pharmaceutical acquisitions processed through this expansive contract framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.9k | 10/30/25 |